In vitro release profiles for INTAC® single entity, FDCs, and multi-modal preparations1-3

INTAC® can be tailored to a variety of release profiles from minutes up to 24 hours

 

References:
1. Bartholomäus J, Schwier S, Brett M, Stahlberg HJ, Galia E, Strothmann K. New abuse deterrent formulation (ADF) technology for immediate-release opioids. Drug Dev Deliv. 2013;13(8):76-81.
2. Wening K, Barnscheid L. Abuse deterrent formulations for fixed-dose combinations and products with multi-modal release properties for opioids and stimulants using INTAC® technology. Poster presented at: AAPS Annual Meeting 2015; Orlando, FL.
3. Wening K, Lehrach I, Schwier S. Novel abuse deterrent immediate release tablets and capsules for opioids containing hot-melt extruded pellets based on the INTAC® technology. Poster presented at: AAPS Annual Meeting 2015; Orlando, FL.  

 

INTAC®